Interchange Capital Partners LLC Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Interchange Capital Partners LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 948 shares of the medical equipment provider’s stock after selling 233 shares during the period. Interchange Capital Partners LLC’s holdings in Intuitive Surgical were worth $490,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new position in Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $492.49 on Monday. The company has a market cap of $175.41 billion, a price-to-earnings ratio of 76.83, a PEG ratio of 5.85 and a beta of 1.43. The stock has a 50 day simple moving average of $562.24 and a 200-day simple moving average of $532.03. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Finally, Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.